(CUB) Lionheart Holdings Complete Analysis Pack
What does Lionheart Holdings do?
Lionheart Holdings is a Cayman Islands special purpose acquisition company, or SPAC, whose Class A ordinary shares trade on Nasdaq under CUB. It seeks a private business, negotiates a combination, obtains approvals, and brings the target to public markets. The company’s 2025 Form 10-K describes a single reportable segment and no operating revenue before a transaction closes.
Why is this different from analyzing an operating company?
An operating-company analysis forecasts demand, revenue, margins, capital spending, and free cash flow. Lionheart’s pre-combination economics instead depend on trust value, redemptions, deal expenses, sponsor incentives, warrant dilution, financing, and target quality. Its equity is an event-driven security rather than a claim on established operating cash flow.
Company identity and security structure
| Item | Current description | Why it matters |
|---|---|---|
| Legal form | Cayman Islands exempted company; incorporated February 21, 2024 | Governance, redemption, and continuation mechanics follow the charter and Cayman law. |
| Listed securities | CUB shares, CUBWU units, and CUBWW warrants on Nasdaq | Each instrument has different downside, redemption, and dilution characteristics. |
| Operating status | No operating revenue through Q1 2026; one pre-combination segment | Reported net income comes from trust interest, not commercial operations. |
| Current transaction stage | Non-binding LOI with KEO Energy announced July 20, 2026 | The target story is emerging, but a definitive agreement has not yet been signed. |
Lionheart therefore matters today as a financing and merger vehicle; its industry identity would change if the KEO Energy transaction progresses.
How does Lionheart Holdings make money?
Lionheart does not yet sell goods or services. The IPO proceeds were placed in a restricted trust invested primarily in money-market funds holding U.S. government securities. Interest increases the redemption value for public shareholders, subject to permitted tax and dissolution withdrawals. In Q1 2026, the trust generated $2.2 million of interest while operating and formation costs were $0.2 million, producing accounting net income of $1.9 million. That profit is not equivalent to distributable operating cash flow because the interest remains substantially within the trust for redemptions or a combination.
What is the economic engine before a merger?
Who bears the costs and who receives the upside?
| Economic stream | Official term | Investor interpretation |
|---|---|---|
| Trust interest | $9.8 million in FY2025 | Supports redemption value but is not operating revenue from a target business. |
| Operating cash burn | $0.6 million used in FY2025 | Outside-trust liquidity funds legal, administrative, diligence, and transaction work. |
| Deferred underwriting fee | $9.8 million payable at a completed combination | Reduces cash available at closing and creates a completion-linked expense. |
| Founder shares and warrants | Sponsor owns 7.7 million founder shares; warrants have an $11.50 exercise price | These instruments create sponsor upside but can dilute public holders after a deal. |
What changed with the proposed KEO Energy transaction?
The July 2026 announcement is the most important strategic development since the IPO. Lionheart’s official LOI press release describes a potential combination with KEO Energy, a wholly owned subsidiary of Keo Capital. The proposed structure would place both parties under a newly formed holding company expected to seek a Nasdaq Capital Market listing.
What would Lionheart be buying?
KEO Energy’s disclosed principal asset is an indirect equity interest in a joint venture holding interests in Venezuela’s PetroUrdaneta Project. The analysis therefore shifts from generic SPAC screening to upstream-energy and geopolitical diligence. Value would depend on ownership rights, reserves, production economics, fiscal terms, capital needs, partners, sanctions compliance, and cross-border cash and equipment movement. Lionheart’s July 20 filing did not yet establish those operating details.
Which conditions could stop or reshape the deal?
| Condition | Status at July 20, 2026 | Analytical consequence |
|---|---|---|
| Definitive agreement | Targeted for August 17, 2026, but not assured | Economics, ownership, financing, and termination provisions remain unsettled. |
| Due diligence and audits | Required before closing | The $400.0 million indicative value may change materially. |
| OFAC authorization | Required under applicable sanctions | U.S. sanctions policy becomes a gating item rather than a peripheral risk. |
| Venezuelan approvals | Hydrocarbon-ministry approval and fiscal terms required | Government policy can affect ownership, economics, timing, and operational control. |
| Shareholder and listing approvals | Still prospective | Redemptions and Nasdaq eligibility could alter available capital and closing certainty. |
What do Lionheart’s latest financial results show?
The Q1 2026 Form 10-Q reported total assets of $248.5 million and total liabilities of $10.2 million. The largest liability was the $9.8 million deferred underwriting fee. Shareholders’ deficit was $10.0 million because public shares are classified outside permanent equity at redemption value.
Why is net income positive while operations consume cash?
Operating and formation costs were $239,801 in Q1 2026, but trust interest of $2.2 million more than offset those expenses in the income statement. Cash flow tells a different story: after removing non-cash trust interest and considering working-capital movements, operations used $112,865. This divergence is normal for a pre-deal SPAC, but it makes outside-trust cash the relevant liquidity metric for ongoing search and negotiation expenses.
Latest quarter versus the FY2025 baseline
| Metric | FY2025 | Q1 2026 | Interpretation |
|---|---|---|---|
| Trust balance | $246.2M at Dec. 31, 2025 | $248.3M at Mar. 31, 2026 | Interest increased value before the June extension redemptions. |
| Interest income | $9.8M for FY2025 | $2.2M for Q1 2026 | The trust remained the sole meaningful income source. |
| Operating costs | $0.9M for FY2025 | $0.2M for Q1 2026 | Costs were modest relative to trust assets but important relative to outside cash. |
| Net income | $9.0M for FY2025 | $1.9M for Q1 2026 | Accounting earnings reflect interest, not an operating margin. |
| Outside cash | $230,540 at Dec. 31, 2025 | $117,675 at Mar. 31, 2026 | The shrinking unrestricted balance raises dependence on sponsor support or other financing. |
How do trust value, redemptions, and dilution shape the economics?
At the June 18, 2026 extraordinary meeting, holders redeemed 4.5 million public shares at approximately $10.88 per share, leaving $201.2 million in trust. The extension-vote Form 8-K also reported that shareholders approved moving the deadline from June 20, 2026 to March 20, 2027.
How much of the original public-share base remained?
Redemptions lower the cash that can support the proposed combination and increase the relative ownership of non-redeeming and sponsor holders. Lionheart also agreed to issue 3.2 million additional Class A shares to institutional holders after a completed business combination in exchange for preserving 15.9 million shares from redemption. The non-redemption agreement filing makes this future issuance explicit. Public warrants, private-placement warrants, target consideration, financing shares, and those new shares all belong in a fully diluted valuation model.
Which strategic turning points explain Lionheart today?
Lionheart’s history is short, but the sequence of financing, governance, extension, and target-selection decisions explains the current risk profile. The timeline is more useful than a conventional corporate-history narrative because each event changes trust value, control, or transaction probability.
-
February 21, 2024Lionheart was incorporated as a Cayman Islands blank-check company, creating the legal shell that would later raise public capital.
-
May 24, 2024The board adopted a compensation clawback policy, establishing a Nasdaq-aligned governance control before the IPO.
-
June 17, 2024The IPO registration statement became effective and the unit terms were finalized, including one share plus one-half warrant per unit.
-
June 20, 2024The IPO closed with 23.0 million units and $230.0 million placed in trust, establishing the transaction capacity and redemption floor.
-
December 31, 2025The trust reached $246.2 million, but the company still had no selected target, making deadline pressure increasingly important.
-
June 6, 2026Lionheart disclosed a priority focus on Venezuelan oil-and-gas opportunities and added energy specialist Freddy J. Martinez as an independent director.
-
June 18–22, 2026Shareholders approved the extension, 4.5 million public shares redeemed, the sponsor converted 3.0 million founder shares, and non-redemption agreements preserved a larger cash pool.
-
July 15–20, 2026Lionheart signed and announced the KEO Energy LOI, converting a broad search mandate into a proposed Venezuela-focused energy transaction.
What did the energy pivot change?
The June appointment of Freddy Martinez was explicitly linked to prioritizing oil-and-gas opportunities in Venezuela. The related director-appointment Form 8-K highlighted his energy-project, Venezuelan fiscal-regime, sanctions, and cross-border finance experience. That governance change now appears strategically connected to the KEO Energy LOI rather than a generic board addition.
Who competes with Lionheart, and what is its real advantage?
Lionheart competes for targets with other SPACs, private-equity funds, strategic acquirers, and operating companies. Many have larger teams, committed financing, sector specialists, and deeper diligence resources. Lionheart’s 2025 filing notes that limited resources constrain target size, while redemptions and warrant dilution can reduce the appeal of its capital.
Does Lionheart have a durable moat?
Not conventionally. A SPAC has no proprietary product, recurring customer base, patent portfolio, or cost advantage. Lionheart’s possible edge is transactional: sponsor relationships, deal flow, structuring experience, and a Nasdaq-listed vehicle backed by trust cash. Its official sponsor profile frames the vehicle as a merger and acquisition platform, while the 10-K emphasizes established businesses with proven unit economics rather than startups.
How should researchers compare Lionheart with alternatives?
| Alternative | Relative strength | Relative weakness |
|---|---|---|
| Other SPACs | Similar listed-shell and redemption mechanics | Competition for targets and financing can compress deal quality. |
| Private equity | Deeper committed capital and operating resources | Does not always offer immediate public-market access to a target. |
| Strategic acquirers | Industry synergies, operating knowledge, and balance-sheet capacity | May offer less autonomy or a different valuation framework to sellers. |
| Traditional IPO | Independent price discovery and no sponsor promote | Can involve a longer, market-sensitive marketing process. |
Who owns Lionheart stock, and why does control matter?
Before the extension vote, Lionheart Sponsor, LLC held all 7.7 million Class B founder shares, equal to 25.0% of the 30.7 million ordinary shares outstanding on May 26, 2026. Ophir Sternberg, Lionheart’s chairman and chief executive, is the sponsor’s sole managing member and controls its voting and investment decisions. After redemptions reduced the public-share count, the sponsor’s proportional influence increased even though its total founder-share position was unchanged.
Which holders were material before the extension?
What governance signals should investors notice?
The May 2026 proxy statement showed a dispersed public base led by event-driven institutions alongside concentrated sponsor control. Public and founder shares generally vote together, but the founder shares carry special pre-combination rights over director appointment and jurisdictional continuation. The board had independent committees, and the June 2026 appointment of Martinez added sector expertise. Still, sponsor incentives differ from public-holder incentives because founder shares and private warrants can become valuable after a deal but may be lost if the SPAC liquidates.
What opportunities and risks could change the story?
Where is the upside?
The opportunity is to combine roughly $200 million of remaining trust capital, as of June 18, 2026, with an energy asset and public-market access. A successful transaction could fund KEO Energy’s growth and create a listed Venezuela oil platform. The proposed six-member combined board, split evenly between Lionheart and KEO appointees, could balance continuity and target knowledge.
Which risks are most material?
| Risk | Financial channel | What to monitor |
|---|---|---|
| LOI failure or repricing | Sunk transaction costs and renewed target search | Definitive agreement, break clauses, and final enterprise value |
| Sanctions and sovereign policy | Delayed closing, restricted operations, or impaired cash flows | OFAC authorization and Venezuelan hydrocarbon rules |
| Redemption and financing risk | Lower cash available and greater dilution | Redemption elections, PIPE terms, debt, and minimum-cash conditions |
| Target concentration | Exposure to one project, commodity cycle, and operating region | Reserve reports, production data, counterparties, and insurance |
| Sponsor conflicts | A deal could preserve sponsor securities even if public returns disappoint | Related-party terms, fairness work, board process, and shareholder vote |
The company’s July Form 8-K announcing the LOI explicitly warns that due diligence, valuation, regulatory approvals, financing, shareholder approval, and listing conditions could prevent completion or materially change the transaction.
Why does Lionheart matter for valuation and DCF analysis?
A standalone DCF of Lionheart before a combination has limited usefulness because there is no operating revenue forecast. Near-term valuation starts with trust cash, subtracts obligations and redemptions, incorporates target economics, and divides by a fully diluted share count. With audited KEO statements and a definitive agreement, analysts could model production, realized prices, operating costs, taxes, capital spending, working interest, fiscal terms, and discount rates reflecting country and sanctions risk.
Which inputs belong in a disciplined model?
| Model block | Current known input | Major missing input |
|---|---|---|
| Trust and cash | About $201.2M after June 2026 redemptions | Cash remaining after future redemptions, taxes, fees, and transaction costs |
| Target valuation | Preliminary $400.0M pre-money enterprise value | Final equity value, debt, cash, ownership split, and adjustment mechanics |
| Operating forecast | PetroUrdaneta-related asset exposure disclosed | Reserves, production, price assumptions, costs, capex, taxes, and partner economics |
| Dilution | Founder shares, public and private warrants, and 3.2M future non-redemption shares | Target shares, financing securities, earnouts, and warrant exercises |
| Discount rate | No company-provided rate | Country, commodity, sanctions, execution, governance, and financing risk premiums |
Comparable-company analysis is also premature because peers depend on the asset, reserves, production profile, fiscal regime, and capital structure. The preliminary enterprise value is not an appraisal, and trust cash is not automatically incremental equity value: consideration, target debt, fees, and dilution determine the bridge.
What should students and investors monitor next?
Lionheart’s next filings should show whether the proposal can become executable. The sequence is a definitive agreement, audited target financials, registration statement, authorizations, financing, shareholder vote, redemptions, and closing. Each step removes uncertainty but may reveal new dilution or operating risk.
- Whether a definitive KEO Energy agreement is signed and how its terms differ from the July 2026 LOI.
- The final enterprise and equity values, including target debt, cash, and any earnout or rollover consideration.
- Audited production, reserves, operating costs, capital requirements, and contractual ownership of the PetroUrdaneta interests.
- OFAC authorization, Venezuelan governmental approvals, and the durability of the applicable sanctions framework.
- The minimum-cash condition and the mix of trust cash, PIPE equity, debt, backstop commitments, or other financing.
- The fully diluted post-closing share count after founder shares, warrants, non-redemption shares, and target consideration.
- Any further extension request before March 20, 2027 if the transaction timetable slips.
What is the key takeaway from Lionheart Holdings analysis?
Lionheart is best understood as a transition vehicle. Its original value proposition was a protected pool of IPO cash plus a sponsor team seeking an established target. The June 2026 extension preserved additional search time but reduced the trust through redemptions and increased sponsor influence. The July 2026 KEO Energy LOI then gave the company a concrete direction: a potential Nasdaq-listed platform tied to a Venezuelan oil project.
That direction is strategically distinctive but analytically demanding. The proposed target may offer resource upside and public-capital access, yet the transaction depends on definitive documentation, audited asset economics, regulatory authorization, Venezuelan approvals, financing, shareholder support, and acceptable dilution. Trust value provides a measurable pre-close anchor for public shares, but it does not validate the preliminary target valuation or guarantee a successful combination.
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.
